Andrew Lee
Overview
Andrew Lee is an angel investor based in San Francisco, California. He is the founder and CEO of Spot Biosystems, a company applying exosomes for drug therapies. He also supports LDV Partners as a part-time venture partner. Additionally, he is the founder of StartX Med, the medical accelerator of Stanford University and Stanford Hospital, and has supported over 350 medical portfolio companies with more than 40 FDA approvals in the biotech, med device, and digital health/AI spaces, totaling over $3.5 billion in cumulative funding since 2012. His portfolio companies include Kodiak (Nasdaq: KOD), CAPP Medical (acquired by Roche), Freenome, and Orca Bio. Andrew Lee has a background in technology and healthcare investments, focusing on early-stage companies in these sectors. His investment strategy emphasizes supporting innovative solutions in biotechnology, medical devices, and digital health. With a track record of over 350 medical portfolio companies and more than 40 FDA approvals, Andrew Lee has demonstrated a strong commitment to advancing healthcare through strategic investments in early-stage companies.
Investment Focus
- Innovative solutions in biotechnology, medical devices, and digital health
Portfolio Companies
Reach Andrew Lee directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Andrew Lee
What sectors does Andrew Lee invest in?
Andrew Lee invests in Financial Services, Technology, Healthcare, Energy, Consumer Goods and Real Estate, and is based in California, United States. Andrew Lee is listed as a angel investor in the ConnectSafely investor database.
What stage does Andrew Lee invest at?
Andrew Lee backs companies at Seed and Early Stage, writing cheques of 1M - 5M.
Which regions does Andrew Lee invest in?
Andrew Lee invests across United States.
What companies has Andrew Lee invested in?
Andrew Lee's portfolio includes Freenome, Orca Bio, Kodiak and CAPP Medical.
Last updated · Source: ConnectSafely investor database
